One-year efficacy and safety of saxagliptin add-on in patients receiving dapagliflozin and metformin.

Matthaei S, Aggarwal N, Garcia-Hernandez P, Iqbal N, Chen H, Johnsson E, Chin A, Hansen L

Open source

DOI
10.1111/dom.12741
Published
2016 Nov
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.12741,
  title = {One-year efficacy and safety of saxagliptin add-on in patients receiving dapagliflozin and metformin.},
  author = {Matthaei S and Aggarwal N and Garcia-Hernandez P and Iqbal N and Chen H and Johnsson E and Chin A and Hansen L},
  year = {2016},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.12741},
  url = {https://doi.org/10.1111/dom.12741}
}

RIS

TY  - JOUR
TI  - One-year efficacy and safety of saxagliptin add-on in patients receiving dapagliflozin and metformin.
AU  - Matthaei S
AU  - Aggarwal N
AU  - Garcia-Hernandez P
AU  - Iqbal N
AU  - Chen H
AU  - Johnsson E
AU  - Chin A
AU  - Hansen L
PY  - 2016
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.12741
UR  - https://doi.org/10.1111/dom.12741
ER  - 

APA

S, M., N, A., P, G., N, I., H, C., E, J., A, C., & L, H. (2016). One-year efficacy and safety of saxagliptin add-on in patients receiving dapagliflozin and metformin.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.12741

Source records